circle-image

Short

Trend Resistance

Uptrend Above: 24150

Bull Market Above: 24330
circle-image

Term

Trend Point Acts

Trend Point: 24130

My PCR: 0.97
309 Range 151

Down Trend Signal

circle-image

View

Trend Suport

Down Below: 24100

Bear Market Below: 23870
Short Term View Historic Data

Nifty View Tomorrow: Thursday 25 Jun 2026

Day Close

24021
Day High

24090
Day Low

23789
Day Avg

23967
24 Jun 2026
5 SMA

24026
10 SMA

23884
20 SMA

23646
50 SMA

23847
200 SMA

24889
5 EMA

24021
10 EMA

23950
20 EMA

23824
50 EMA

23924
Tomorrow
Resist 2

24300
Resist 1

24160
Mid Point

24020
Suport 1

23860
Suport 2

23700
52W High

26373
52w Low

22182
52w Down

8.92%
52w Up

8.29%
Panic View
Resist 2

24570
Resist 1

24365
Mid Point

24000
Suport 1

23620
Suport 2

23380
5d High

24189
5d Low

23784
10d High

24189
10d Low

23072
Days High & Low 20d High

24189
20d Low

23070
50d High

24601
50d Low

23070
All Avg

23771
FFTH

24054
FTTL

23682
TTTH

23817
TTTL

23444
High & Low Avg TTFH

23953
TFFL

23580
High Avg

23941
Low Avg

23569
All Avg

23755
Nifty Historic Prediction Data

Nifty Last Five Days Moves

SNo. Date Day Close Day High Day Low 5 DMA 10 DMA 20 DMA 50 DMA 200 DMA
1 24 Jun 2026 24021 24090 23789 24026 23884 23646 23847 24889
2 23 Jun 2026 23824 24135 23784 24038 23803 23641 23848 24892
3 22 Jun 2026 24102 24168 24073 24071 23745 23651 23847 24895
4 19 Jun 2026 24013 24047 23901 24022 23647 23632 23845 24897
5 18 Jun 2026 24168 24189 24036 23943 23582 23614 23827 24900
Nifty Historic Data And Moving Avg

Go Back

Akums Drugs & Pharmaceuticals Ltd the largest India-focused CDMO in terms of revenue, productio...

Posted: 03 Nov 2024

Akums Drugs & Pharmaceuticals Ltd the largest India-focused CDMO in terms of revenue, production capacity and clients served during the Financial Year 2023 (among CDMOs assessed by F&S) (Source: F&S Report). Research and Development 4 Research and Development (R&D) Units drives our continuous efforts in product development, ensuring innovative solutions. Pharmaceutical Manufacturer we are a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. As one of the leading CDMOs in India, we own the intellectual property for the manufacturing processes of several of our formulations, and our core business is focused on providing end-to-end product development and manufacturing solutions to our clients. Some of our other services include formulation research and development (R&D), preparation and filing of regulatory dossiers in the Indian and global markets, and other testing services. Research & Development (R&D) and Quality Assurance Unwavering dedication to cutting-edge research and development, ensuring product efficacy and safety through stringent quality assurance measures. Quality Our customers can trust us to deliver quality products available in our industry. We are committed to providing only the quality products for our customers, every step of the way. We stand behind every product and service we provide. We are proud to be a company that puts quality first, and we will never waver in our quest for excellence. Delivery We understand the importance of reliability and punctuality in today's fast-paced business world and we are dedicated to working hard to ensure that our customers can always count on us for reliable delivery and service. When it comes to deliveries and services, our word is our bond and we will never let our customers down. Customer satisfaction is our top priority and are dedicated to delivering products that exceed expectations. Innovation We are constantly striving to improve our products by bringing innovation and creativity. Our success is due to our ability to provide the quality products to our customers. Every day is a new challenge and we are excited for all the new opportunities that come our way. Innovation is the lifeblood of our company and we will always strive to be the best in our business. Nutraceutical Manufacturer Akums meets the escalating demand for health and wellness products with expertise and precision. By translating nutraceutical concepts into tangible products, Akums empowers businesses to cater to the health-conscious consumer base. Its state-of-the-art manufacturing facilities and unwavering commitment to maintaining the highest quality standards ensure that the nutraceutical products produced are safe, effective, and aligned with consumer expectations. This vital role strengthens the health and wellness industry in India, fostering a culture of well-being and balanced living. API Manufacturer Following the acquisition of Parabolic Drugs by our Company in 2021, we entered the business of the manufacture and sale of key starting materials, intermediates and APIs, and acquired manufacturing units in Dera Bassi and Lalru in Punjab and Barwala in Haryana, and an R&D centre in Barwala, Haryana. Details of our API units are set out below: Dera Bassi, Punjab: This unit is dedicated to the production of beta lactams and is equipped with six production blocks. With an annual capacity of 557.00 MT. This unit enables us to carry out complex multistep synthesis processes, meeting the high demand for beta lactam APIs. Lalru, Punjab: This unit is designed for the synthesis of a wide range of APIs spanning various therapy areas. This unit comprises three production blocks and has an annual production capacity of 180.00 MT. At this unit, we produce APIs across a broad spectrum of therapeutic categories. Barwala, Haryana: This unit is a specialized small-volume, high-potency API manufacturing unit with an annual production capacity of 0.38 MT. This unit features a kilo lab scale pilot plant for experimental and development purposes and is dedicated to handling high-potency APIs with a high degree of expertise.

Market Bits

"In investing, what is comfortable is rarely profitable." — Robert Arnott

Be prepared to invest in a down market and to "get out" in a soaring market, as per the philosophy of Warren Buffett.